MARKETS
Earnings

Sophia Genetics Q2 EPS $(0.30) Misses $(0.20) Estimate, Sales $23.310M Beat $21.729M Estimate

Aug 4, 2026 · 06:46 AM ET· updated 2h ago

Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.20) by 50 percent. This is a 9.09 percent increase over losses of $(0.33) per share from

Share
Why It Matters

Sophia Genetics lost more money per share than experts predicted, but their sales grew faster than expected. When a company loses money but sells more stuff, it means they're growing—even if they're not profitable yet.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.